Go-to-Brazil Program
Before you spend a cent, know exactly where you are going
What the Go-to-Brazil Program is
The Go-to-Brazil Program is a complete market entry diagnostic for Brazil. In 6 to 10 weeks we map every regulatory, technical and commercial gap in your product and deliver an entry plan with a timeline, a budget and concrete next steps. This is not theory: it is the map of the territory before you invest in the land.
Knowledge
You are about to enter Brazil without knowing which segment holds the most potential for your product.
Distribution
You have heard the stories: manufacturers who picked the wrong distributor and lost two years of runway.
Regulation
You do not know whether ANVISA’s requirements for your product are simple or complex — and that worries you.
Board
You are under pressure to show the board or your investors a convincing entry plan.
Do any of these sound familiar?
Enter Brazil the right way in 2026 and you set the market’s reference price for years. Enter the wrong way and you pay to find out what the right way was.“
What We Do
| ✓ Full regulatory analysis: risk classification, ANVISA petition route and a realistic timeline ✓ Technical gap analysis: what is missing from your performance data for the Brazilian dossier ✓ Market sizing by segment: potential volume, current penetration and competitive intensity ✓ Distributor qualification: a shortlist scored against seven criteria ✓ Competitive analysis: registered products, positioning and your competitors’ blind spots ✓ KOL mapping: the opinion leaders who actually drive adoption in your segment ✓ Non-consumer assessment: segments with unmet demand that no competitor is working |
What you receive
| ✓ Gap Analysis report covering regulatory, technical and commercial dimensions ✓ Market Map with sizing by segment and competitive intensity ✓ Distributor qualification scorecard (shortlist) ✓ Entry Plan with timeline, budget and decision milestones ✓ Competitive Radar showing where the main players sit ✓ Priority segment recommendation, with the numbers behind it |
Free tool: Before you engage anyone, find out which risk class your product falls into and what is missing from the dossier. It takes about 10 minutes, it is free and it requires no sign-up. Open ANVISA Readiness.
“Entering Brazil without a strategic diagnostic is like operating without anaesthetic: painful, expensive and avoidable.”
